NVCR News and Press, NovoCure Limited

2024-07-26 12:34:32 ET Summary Today, we take a look at NovoCure Limited, which develops and manufactures tumor treating fields devices for solid tumor cancers. The company has beat expectations for both its first and second quarter results in 2024 and is pushing to garner approva...

2024-07-25 17:30:15 ET Image source: The Motley Fool. NovoCure (NASDAQ: NVCR) Q2 2024 Earnings Call Jul 25, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: NovoCure (NVCR) Q2 2024 Earnings Call Transcript

2024-07-25 12:35:09 ET NovoCure Limited [NVCR] Q2 2024 Earnings Conference Call July 25, 2024, 8:00 a.m. ET Company Participants Bill Doyle - Executive Chairman Asaf Danziger - CEO Ashley Cordova - CFO Frank Leonard - EVP and President of NovoCure Oncology ...

2024-07-25 07:01:24 ET More on NovoCure NovoCure Limited Q1 Earnings: Core Business Accelerating NovoCure Limited (NVCR) Q1 2024 Earnings Call Transcript NovoCure Limited 2024 Q1 - Results - Earnings Call Presentation NovoCure Q2 2024 Earnings Preview ...

Quarterly net revenues of $150 million, up 19% year-over-year, with 3,963 active patients on therapy as of June 30, 2024 Positive results from Phase 3 METIS trial in brain metastases from non-small cell lung cancer presented at ASCO 2024 Novocure (NASDAQ: NVCR) today reported fi...

2024-07-24 13:32:42 ET More on NovoCure NovoCure Limited Q1 Earnings: Core Business Accelerating NovoCure Limited (NVCR) Q1 2024 Earnings Call Transcript NovoCure Limited 2024 Q1 - Results - Earnings Call Presentation NovoCure Tumor Treating Fields decreases ...

Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial markets open. Novocure management will host a conference call and webcast to discuss the company’s financial results for the three...

2024-06-13 14:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-09 16:23:25 ET Read the full article on Seeking Alpha For further details see: Stocks with the highest and lowest liquidity - Goldman Sachs

2024-06-06 09:07:10 ET Summary AstraZeneca PLC showcased projects in two plenary lecture presentations at the Annual Meeting of the American Society of Clinical Oncology, or ASCO, including a trial that established osimertinib as the standard of care for EGFR-mutant NSCLC. Bristol...